Nadia Assenova MPharm, MBA, MSc is Senior Director, Regulatory Affairs leading the EMEA regulatory team at Alexion in Zurich. She has over 14 years of experience in global regulatory affairs. She joined Alexion in 2015 focusing on the registration of orphan medicinal products across the globe. Throughout her career, Nadia has lead regulatory submissions in various therapeutic areas, most recently focusing on development of new indications in ultra-rare diseases and regulatory strategy for the metabolic products within the Alexion pipeline. Nadia received her Pharmacy MSc degree from the University of Medicine in Sofia (Bulgaria). She also holds an MBA from the University of Strathclyde (UK) and M.Sc. in Health Policy from Imperial College London (UK).